"Solving the collagen problem means solving the skin problem." However, the functional ingredients that promote collagen production often come with certain irritants or fail to deliver ideal results. In contrast, recombinant collagen is homologous to human collagen, eliminating the risk of rejection. Its mechanism is clear, and it can directly promote the body's own collagen production.
Produced through gene recombination and biological fermentation, recombinant collagen is identical in amino acid sequence to natural human collagen. This ensures high bioactivity and overcomes challenges such as immune rejection, which are common with animal-derived alternatives. By employing "molecular compression" technology, VEMINSYN reduces the molecular size while preserving its core functions, effectively unlocking the transdermal absorption capability that standard collagen lacks.
Cruelty-free
Low energy consumption
Low carbon footprint
Biodegradable
No animal farming or extraction required
Streamlined production chain
Lower cost
Human-compatible
No immunogenic rejection
Transdermal delivery
Binding affinity
Anti-aging approach
